EUVIMEDEUVIMED entdecken
Crossref

Cd44 Targeted Delivery of Hyaluronic Acid-Coated Polymeric Nanoparticles Against Colorectal Cancer

Niraj Phatak iD, Sankha Bhattacharya iD, Disha Shah iD, Laxmi Manthalkar iD, Putrevu Sreelaya iD, Arinjay Jain iD

Nanomedicine · 2023-10 · 18 (23) · 1613-1634

DOI: 10.2217/nnm-2023-0145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanomedicine, online erschienen am 13.10.2023. Verfasst von Niraj Phatak und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy & Technology Management, Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies, Deemed-to-Be University,…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Colonic Neoplasms, Nanoparticles. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To develop hyaluronic acid (HA)-coated poly-lactic-co-glycolic acid (PLGA)-polysarcosine (PSAR) coupled sorafenib tosylate (SF) polymeric nanoparticles for targeted colon cancer therapy. Materials & methods: PLGA-PSAR shells were encapsulated with SF via nanoprecipitation. Interactions were examined with transmission electron microscopy, revealing formulation component interactions.

Results

The optimized HA-coated polymeric nanoparticles (238.8 nm, -6.1 mV, 68.361% entrapment) displayed enhanced controlled release of SF. These formulations showed superior cytotoxicity against HCT116 cell lines compared with free drug (p < 0.05). In vivo tests on male albino Wistar rats demonstrated improved pharmacokinetics, targeting and biocompatibility. HA-coated PLGA-PSAR-coupled SF polymeric nanoparticles hold potential for effective colorectal therapy.

Conclusion

Colon cancer may be precisely targeted by HA-coated PLGA-PSA-coupled SF polymeric nanoparticles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsColonic NeoplasmsNanoparticlesAnimalsMaleRatsCell Line, TumorDrug CarriersHyaluronic AcidLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid Copolymer

Stichwörter der Autor:innen

CD44 receptorHCT116colorectal cancerhyaluronic acidpolymeric nanoparticlessorafenib tosylatetargeted drug delivery

Substanzen

Antineoplastic AgentsDrug CarriersHyaluronic AcidLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid Copolymer

Autor:innen und Institutionen

  • School of Pharmacy & Technology Management, Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies, Deemed-to-Be University, Shirpur, Maharashtra, 425405, India.

ORCID-Profile: Niraj Phatak, Sankha Bhattacharya, Disha Shah, Laxmi Manthalkar, Putrevu Sreelaya, Arinjay Jain

Zitieren

APA

Phatak, N., Bhattacharya, S., Shah, D., Manthalkar, L., Sreelaya, P., & Jain, A. (2023). Cd44 Targeted Delivery of Hyaluronic Acid-Coated Polymeric Nanoparticles Against Colorectal Cancer. Nanomedicine, 18(23), 1613-1634. https://doi.org/10.2217/nnm-2023-0145

Vancouver

Phatak N, Bhattacharya S, Shah D, Manthalkar L, Sreelaya P, Jain A. Cd44 Targeted Delivery of Hyaluronic Acid-Coated Polymeric Nanoparticles Against Colorectal Cancer. Nanomedicine. 2023;18(23):1613-1634. doi:10.2217/nnm-2023-0145

BibTeX
@article{Phatak2023,
  author = {Phatak, Niraj and Bhattacharya, Sankha and Shah, Disha and Manthalkar, Laxmi and Sreelaya, Putrevu and Jain, Arinjay},
  title = {Cd44 Targeted Delivery of Hyaluronic Acid-Coated Polymeric Nanoparticles Against Colorectal Cancer},
  journal = {Nanomedicine},
  year = {2023},
  volume = {18},
  number = {23},
  pages = {1613--1634},
  doi = {10.2217/nnm-2023-0145}
}
Kostenlos starten →